Metformin-associated lactic acidosis and acute kidney injury in the era of COVID-19

4Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

COVID-19, provoked by SARS-CoV-2, constitutes a global health issue with high rates of mortality. The presence of diabetes mellitus is associated with severe coronavirus COVID-19 as it is related to increased death rates in patients admitted to the intensive care unit. Acute kidney injury is a frequent complication among patients hospitalized for COVID-19 and is met with high morbidity and mortality. Here, we present a case of a diabetic patient with acute kidney injury, metformin-associated lactic acidosis, and COVID-19. Lactic acidosis is a relatively rare but noteworthy complication of metformin use. However, the combination of those life-threatening situations could prove fatal for the patients despite optimal medical care.

Cite

CITATION STYLE

APA

Vordoni, A., Theofilis, P., Vlachopanos, G., Koukoulaki, M., & Kalaitzidis, R. G. (2021). Metformin-associated lactic acidosis and acute kidney injury in the era of COVID-19. Frontiers in Bioscience - Scholar, 13(2), 202–207. https://doi.org/10.52586/S563

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free